Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

I-191 is an antagonist of proteinase-activated receptor 2 (PAR2; IC50 = 72.4 nM in HT-29 cells expressing the human receptor).1 It inhibits trypsin-induced calcium release in HT-29 cells (IC50 = 200 nM for the human receptor). I-191 (0.1, 1, and 10 µM) reduces the migration of HT-29 cells in a scratch assay. It decreases the expression of mRNA encoding chemokine (C-X-C motif) ligand 8 (CXCL8) in, and secreted IL-8 levels from, HT-29 cells induced by the PAR2 agonist 2f-LIGRL-NH2 when used at a concentration of 1 and 10 µM. Ex vivo, I-191 (10 µM) inhibits tissue factor-induced clotting using isolated human whole blood.2
WARNING This product is not for human or veterinary use.
1. A potent antagonist of protease-
2. PAR2 activation on human kidney tubular epithelial cells induces tissue factor synthesis, that enhances blood clotting. Front. Physiol. 12, 615428 (2021).